Published: Journal of Analytical Toxicology, Volume 20, Number 4, July/August 1996, pp. 224-228.
HPLC Determination of Cocaine and Benzoylecgonine in Plasma
and Urine from Drug Abusers
P. Fernández, N. Lafuente, A.M. Bermejo, M. López-Rivadulla,
and A. Cruz
Reversed-phase high-performance liquid chromatography (HPLC) was used for the determination of cocaine and its metabolite, benzoylecgonine (BZE), in plasma and urine. Following a solid–liquid extraction with Bond-Elut Certify cartridges and using methaqualone as reference compound, chromatography was performed with a Lichrospher RP 18 (125 ¥ 4-mm i.d.) reversed-phase column, ultraviolet (UV) detection at 235 nm, and methanol (pH 7)–phosphate buffer (70:30, v/v) as mobile phase. Linearity was obtained from 0.1 to 20 µg/mL with a good correlation coefficient. Recoveries ranged from 76.9 to 96.5%, and coefficients of variation were always less than 5.0%. Urine samples from live, cocaine-intoxicated patients contained concentrations of 0.21–75.55 µg/mL BZE and less than 4.14 µg/mL cocaine, whereas postmortem urine analyses gave concentrations of 5.86–198.76 µg/mL for BZE and 1.56–33.24 µg/mL for its parent compound. Finally, postmortem blood samples were all negative for cocaine and gave BZE concentrations of 0.040–0.53 µg/mL.
Reproduction of editorial content of this journal is prohibited without publisher’s permission.
| This article is available in its entirety by fax for $40.00 each. Visa, MasterCard and AMEX accepted. To order electronically click
here Please indicate JAT volume and issue along with page numbers. |
| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |